Supplementary Text from Proteomic Signature Corresponding to the Response to Gefitinib (Iressa, ZD1839), an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma

Authors:
  • TOTetsuya Okano
    Tetsuya Okano
  • TKTadashi Kondo
    Tadashi Kondo
  • KFKiyonaga Fujii
    Kiyonaga Fujii
  • TNToshihide Nishimura
    Toshihide Nishimura
  • TTToshimi Takano
    Toshimi Takano
  • YOYuichiro Ohe
    Yuichiro Ohe
  • KTKoji Tsuta
    Koji Tsuta
  • YMYoshihiro Matsuno
    Yoshihiro Matsuno
  • AGAkihiko Gemma
    Akihiko Gemma
  • HKHarbumi Kato
    Harbumi Kato
  • SKShoji Kudoh
    Shoji Kudoh
  • SHSetsuo Hirohashi
    Setsuo Hirohashi

Abstract
Supplementary Text from Proteomic Signature Corresponding to the Response to Gefitinib (Iressa, ZD1839), an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma